| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dc5fdf0f2197acd126d78225df71a935 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-34 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496 |
| filingDate |
2020-12-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a8d212cfa2f4dea0f38c951fc25b22a8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cac15c8ff15338880da97c48b4a6ab28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_822d882f792fe9e166c81206e6629131
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9bf24b6e5da4299c83c92df50988ff18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7eb0b41047821072a348c0248c2e38cd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f778c9f411b44de8db16eb05023c8334 |
| publicationDate |
2021-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2021112620-A1 |
| titleOfInvention |
Pharmaceutical composition for prevention or treatment of sarcopenia or muscle atrophy |
| abstract |
The present invention relates to a pharmaceutical composition comprising an indirubin derivative as an active ingredient for prevention or treatment of sarcopenia or muscle atrophy and a method for treatment of sarcopenia or muscle atrophy by using same. The present invention relates to a novel use of an indirubin derivative in treating sarcopenia or muscle atrophy. The pharmaceutical composition provided by the present invention can be advantageously used for effectively preventing or treating sarcopenia or muscle atrophy through the increase of myotube diameters, the suppression of myotube atrophy, the maintenance of ratios of myotubes by diameter, and the expression downregulation of gene atrogine-1, which destroys muscle proteins. |
| priorityDate |
2019-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |